Rona Therapeutics

📍 shanghai, China🗓 Founded 2021👥 17 employees💰 Last funded Sep 2025
Biotechnology Research🌐 ronatherapeutics.com
Website LinkedIn
Rona Therapeutics is a pioneering nucleic acid therapeutics company to discover, develop and deliver transformative modular RNA medicines to treat patients globally. Rona Therapeutics is a global leader in nucleic acid innovative drug platform company, specializing in the treatment of metabolic diseases and neurological diseases. Rona Therapeutics is always committed to developing the best and first-in-class siRNA drugs with differentiation and innovation to address unmet needs and improve outcome in cardiovascular diseases, obesity, and MASH. In addition, Rona Therapeutics is unlocking potential of extra-hepatic delivery for neurological disorders and adipose/muscle delivery for various metabolic syndromes.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
China
1
Frequently asked questions
Who invested in Rona Therapeutics?
Rona Therapeutics has 1 investors on record on gritt.io, 1 mid-stage.
When did Rona Therapeutics last raise funding?
The most recent investment in Rona Therapeutics recorded on gritt.io was in September 2025.
When was Rona Therapeutics founded?
Rona Therapeutics was founded in 2021.
What industry is Rona Therapeutics in?
Rona Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Rona Therapeutics based?
Rona Therapeutics is headquartered in shanghai, China.